Trimi vs Enhance MD: Semaglutide pricing, shipping, refunds
Quick verdict: For lower first-month entry cost choose Enhance MD; for ongoing flat low monthly price, free overnight shipping, and a 6-month money-back promise choose Trimi. This comparison looks at pricing structure, shipping and refunds, compound options and clinical scale to answer Trimi vs Enhance MD.
Trimi vs Enhance MD: pricing and billing model
Both providers use clinician-directed prescribing and offer compounded semaglutide and tirzepatide options, and both note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. The most distinctive pricing difference is entry cost versus ongoing plan structure.
Entry and ongoing prices
- Trimi: Semaglutide from $99/mo on the annual plan; tirzepatide $125/month on annual plans. Trimi emphasizes flat pricing that never rises as dose increases.
- Enhance MD: Semaglutide from $49 for the first month and tirzepatide from $99 for the first month. Enhance MD presents these as introductory first-month prices, with an ongoing flat-rate that is higher.
View Enhance MD first-month offers
Trimi vs Enhance MD: shipping, fulfillment, and refunds
Shipping and refund policies are another clear contrast in the Trimi vs Enhance MD comparison.
Shipping and pharmacy handling
- Trimi: Free overnight, temperature-controlled shipping and medications compounded by state-licensed 503A pharmacies, with named pharmacies and certificate of analysis available on request.
- Enhance MD: Landing-page material captures promotional offers and pricing but does not emphasize free overnight shipping in the captured evidence.
Refunds and consumer protections
- Trimi: Offers a 6-month money-back promise. The text: “Follow your plan for 6 months, and if you don’t lose weight, you can request a refund. Terms apply.”
- Enhance MD: No comparable money-back promise was supplied in the captured evidence.
Check Trimi shipping and refund details
Trimi vs Enhance MD: compound options and clinical scale
Both platforms prescribe clinician-directed compounded semaglutide and tirzepatide, but they position their offerings differently.
Compound availability
- Trimi: Offers compounded tirzepatide and semaglutide prescribed by US-licensed clinicians and shipped to your door.
- Enhance MD: Offers both semaglutide and tirzepatide, with the $49/$99 rates explicitly described as first-month introductory prices and both compounds available on one platform.
Clinical scale and claims
- Trimi: Notes that prescriptions are reviewed by licensed U.S. providers through Arora Health, a network led by a named medical director, and lists specific compounding pharmacies by name in the captured evidence.
- Enhance MD: Cites treatment of 10,000+ patients as captured on the landing page and positions itself as a transparent multi-option platform with large clinical volume.
Comparison table: Trimi vs Enhance MD
| Criterion | Trimi | Enhance MD |
|---|---|---|
| Starting semaglutide price | Semaglutide from $99/mo on the annual plan | Semaglutide from $49 first month |
| Tirzepatide price | Compounded Tirzepatide $125/month on annual plans | Tirzepatide from $99 first month |
| Flat pricing as dose increases | Flat pricing that never rises as your dose increases | Flat-rate pricing: same price at every dose after intro |
| Shipping | Free overnight, temperature-controlled shipping | Shipping details not emphasized in captured evidence |
| Refunds or guarantees | 6-month money-back promise; terms apply | No money-back promise captured |
| Clinical scale / volume | Licensed U.S. providers via Arora Health; named compounding pharmacies listed | 10,000+ patients treated according to landing-page evidence |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
How they differ most
The three to five most distinctive supported differences in Trimi vs Enhance MD are clear from the captured evidence: initial entry price vs first-month promotions, shipping and named compounding pharmacies, a formal 6-month money-back promise at Trimi, and Enhance MD’s large reported patient volume and low first-month pricing.
Other evidence gaps
Where evidence is absent it is not supplied by the captured source material. For example, specific ongoing monthly pricing after Enhance MD introductory months varies in the captured landing evidence and exact ongoing rates were not consistently published in the captured snippets.
Conclusion: Choose Trimi vs Enhance MD
Choose Trimi if you want compounded semaglutide from $99/mo on an annual plan, free overnight, temperature-controlled shipping, named state-licensed 503A pharmacies and a 6-month money-back promise. Choose Enhance MD if you prioritize the lowest first-month entry price for semaglutide or tirzepatide and a platform that has treated 10,000+ patients.